Thousands of delegates, advocates, and people living with HIV came together July 22 for the AIDS 2014 Mobilization March and candlelight vigil, held in conjunction with the 20th International AIDS Conference taking place this week in Melbourne. Key themes of the march included the need for more funding to expand access to HIV prevention and treatment, and an end to discrimination and criminalization of people with HIV and at-risk groups including gay men, sex workers, and people who use drugs.
iPrEx OLE, the open-label extension of the iPrEx study of pre-exposure prophylaxis (PrEP), reported its main findings this week at the 20th International AIDS Conference in Melbourne, Australia, published simultaneously in The Lancet Infectious Diseases. Overall PrEP effectiveness was 50% overall, but 100% in those taking 4 or more doses per week. There was a substantial early drop-out rate, especially among young people.
Progress along the multi-pronged path towards a cure for HIV was one of the themes at the 20th International AIDS Conference (AIDS 2014), taking place this week in Melbourne. Researchers provided updates on the "Mississippi Baby," a novel assay for detecting low levels of hidden virus in the body, and using the anti-cancer drug romidepsin to reactivate latent virus.
Sex workers from more than 30 countries came together this week at the Sex Worker Pre-Conference preceding the 20th International AIDS Conference in Melbourne to consider proposed changes to policy and funding approaches aimed at positioning human rights as critical to the response to HIV/AIDS.